BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 215.00
+15.00 (7.50%)
At close: Feb 13, 2026
BioInfra Life Science Market Cap
BioInfra Life Science has a market cap or net worth of 4.66 billion as of February 13, 2026. Its market cap has decreased by -44.73% in one year.
Market Cap
4.66B
Enterprise Value
n/a
Revenue
1.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
215.00
Market Cap Chart
Since July 22, 2020, BioInfra Life Science's market cap has decreased from 57.13B to 4.66B, a decrease of -91.85%. That is a compound annual growth rate of -36.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.66B | -21.82% |
| Dec 30, 2025 | 5.96B | -33.89% |
| Dec 30, 2024 | 9.01B | 75.26% |
| Dec 28, 2023 | 5.14B | -65.89% |
| Dec 29, 2022 | 15.08B | -60.07% |
| Dec 30, 2021 | 37.76B | -10.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corentec | 85.41B |
| DENTIS CO.,Ltd | 65.45B |
| Alpha AI | 42.21B |
| Celemics | 40.37B |
| Finemedix | 39.64B |
| Genolution | 32.70B |
| TASCOM | 22.85B |
| Sanigen Co. | 12.81B |